{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:38:50Z","timestamp":1790987930048,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.neuro.2008.07.005","type":"journal-article","created":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T08:12:39Z","timestamp":1218010359000},"page":"1030-1036","source":"Crossref","is-referenced-by-count":49,"title":["Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats"],"prefix":"10.1016","volume":"29","author":[{"given":"Katsutoshi","family":"Shioda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nisijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Kuboshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Yui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2008.07.005_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/syn.20421","article-title":"Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice","volume":"61","author":"Ago","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.neuro.2008.07.005_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2003.12.004","article-title":"Baclofen prevents MDMA-induced rise in core body temperature in rats","volume":"74","author":"Bexis","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuro.2008.07.005_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00213-005-0012-9","article-title":"Clozapine increases cutaneous blood flow and reduced sympathetic cutaneous vasomotor altering response (SCVARs) in rats: comparison with effects of haloperidol","volume":"181","author":"Blessing","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuro.2008.07.005_bib4","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1523\/JNEUROSCI.23-15-06385.2003","article-title":"Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (Ecstasy) in rabbits and rats","volume":"23","author":"Blessing","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.07.005_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0022-3565(25)10672-1","article-title":"Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality","volume":"274","author":"Bronstein","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.neuro.2008.07.005_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuro.2008.07.005_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/BF02044131","article-title":"MDMA induced hyperthermia: report of a fatality and review of current therapy","volume":"22","author":"Dar","year":"1996","journal-title":"Intens Care Med"},{"key":"10.1016\/j.neuro.2008.07.005_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.5694\/j.1326-5377.1996.tb122252.x","article-title":"Deaths attributed to \u201cecstasy\u201d overdose","volume":"164","author":"Dowsett","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.neuro.2008.07.005_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00213-005-0149-6","article-title":"Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"183","author":"Freedman","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuro.2008.07.005_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1520\/JFS15211J","article-title":"Ecstasy (MDMA) deaths in New York City: a case series and review of the literature","volume":"47","author":"Gill","year":"2002","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.neuro.2008.07.005_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","article-title":"Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity","volume":"95","author":"Gillman","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.neuro.2008.07.005_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(91)90288-D","article-title":"Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat","volume":"38","author":"Gordon","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2008.07.005_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.2002.tb04182.x","article-title":"Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study","volume":"965","author":"Gough","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neuro.2008.07.005_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.bjp.0706318","article-title":"Studies on the effect of MDMA (\u2018ecstasy\u2019) on the body temperature of rats housed at different ambient room temperatures","volume":"146","author":"Green","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of \u2018Ecstasy\u2019 (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.neuro.2008.07.005_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130050820","article-title":"Effect of 5-HT2 receptor antagonists on a cranial nerve reflex in the rabbit: evidence for inverse agonism","volume":"141","author":"Harvey","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuro.2008.07.005_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-004-2030-4","article-title":"Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine","volume":"178","author":"Herin","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuro.2008.07.005_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(93)90859-G","article-title":"5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits","volume":"238","author":"Huang","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0022-3565(24)37012-0","article-title":"The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist NAD-299","volume":"283","author":"Johansson","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2008.07.005_bib20","first-page":"265","article-title":"Affinity of neuroleptics for D1 receptor of human brain striatum","volume":"19","author":"Kanba","year":"1994","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.neuro.2008.07.005_bib21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0091-3057(97)00527-3","article-title":"The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens","volume":"59","author":"Kankaanpaa","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2008.07.005_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.1996.tb15208.x","article-title":"In vitro and in vivo profile of SB 206553 a potent 5-HT2C\/5-HT2B receptor antagonist with anxiolytic-like properties","volume":"117","author":"Kennett","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","article-title":"SB 242084 a selective and brain penetrant 5-HT2C receptor antagonist","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2008.07.005_bib24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00101-003-0474-2","article-title":"Hyperpyrexia and rhabdomyolysis after ecstasy (MDMA) intoxication]","volume":"52","author":"Kunitz","year":"2003","journal-title":"Anaesthesist"},{"key":"10.1016\/j.neuro.2008.07.005_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3565(25)13416-2","article-title":"Biochemical profile of risperidone, a new antipsychotic","volume":"247","author":"Leysen","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2008.07.005_bib26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/emj.14.5.336","article-title":"MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9\u00b0C.","volume":"14","author":"Mallick","year":"1997","journal-title":"J Accid Emerg Med"},{"key":"10.1016\/j.neuro.2008.07.005_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02245187","article-title":"Evidence that 1-(2,5-dimethoxy-4-iodophnyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors","volume":"117","author":"Mazzola-Pomietto","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuro.2008.07.005_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","article-title":"The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA \u2018ecstasy\u2019) to rats","volume":"135","author":"Mechan","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)39332-2","article-title":"S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626","volume":"293","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"3 Pt 1","key":"10.1016\/j.neuro.2008.07.005_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0196-0644(98)70018-6","article-title":"Death by \u201cecstasy\u201d: the serotonin syndrome?","volume":"32","author":"Mueller","year":"1998","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.neuro.2008.07.005_bib31","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/0024-3205(90)90484-9","article-title":"Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis","volume":"47","author":"Nash","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.neuro.2008.07.005_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002130000397","article-title":"Risperidone counteracts lethality in an animal model of the serotonin syndrome","volume":"150","author":"Nisijima","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuro.2008.07.005_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(00)03020-1","article-title":"Potent serotonin (5-HT)2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome.","volume":"890","author":"Nisijima","year":"2001","journal-title":"Brain Res"},{"issue":"507","key":"10.1016\/j.neuro.2008.07.005_bib34","first-page":"510","article-title":"Hazards associated with the recreational drug \u2018ecstasy\u2019","volume":"52","author":"O\u2019Connor","year":"1994","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.neuro.2008.07.005_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(02)02654-7","article-title":"Pharmacological profiles of R-96544: the active form of a novel 5-HT2A receptor antagonist R-102444","volume":"457","author":"Ogawa","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hup.351","article-title":"Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research","volume":"16","author":"Parrott","year":"2001","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.neuro.2008.07.005_bib37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-3057(01)00711-0","article-title":"Recreational ecstasy\/MDMA, the serotonin syndrome, and serotonergic neurotoxicity","volume":"71","author":"Parrott","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2008.07.005_bib38","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuro.2008.07.005_bib39","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.mcna.2005.06.002","article-title":"Toxin-induced hyperthermic syndromes","volume":"89","author":"Rusyniak","year":"2005","journal-title":"Med Clin N Am"},{"issue":"7380","key":"10.1016\/j.neuro.2008.07.005_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bmj.326.7380.80","article-title":"Review of deaths related to taking ecstasy, England and Wales 1997\u20132000","volume":"326","author":"Schifano","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.neuro.2008.07.005_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(92)90819-P","article-title":"5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue 3,4-methylenedioxymethamphetamine","volume":"223","author":"Schmidt","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuro.2008.07.005_bib44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pnpbp.2004.01.013","article-title":"Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine","volume":"28","author":"Shioda","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuro.2008.07.005_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/00048670701449237","article-title":"Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk","volume":"41","author":"Silins","year":"2007","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.neuro.2008.07.005_bib46","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2044.1992.tb02391.x","article-title":"An overdose of ecstasy: a role for dantrolene","volume":"47","author":"Singarajan","year":"1992","journal-title":"Anaesthesia"},{"key":"10.1016\/j.neuro.2008.07.005_bib47","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.CCM.0000165969.29002.70","article-title":"Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA Ecstasy) in an animal model","volume":"33","author":"Sprague","year":"2005","journal-title":"Crit Care med"},{"key":"10.1016\/j.neuro.2008.07.005_bib48","unstructured":"TOCRIS Cookson Ltd. Company Data. http:\/\/www.tocris.com\/products\/R-96544.php."},{"key":"10.1016\/j.neuro.2008.07.005_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0091-3057(03)00194-1","article-title":"Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior","volume":"76","author":"Uphouse","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2008.07.005_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1360-0443.2003.00292.x","article-title":"Death following ingestion of MDMA (ecstasy) and moclobemide","volume":"98","author":"Vuori","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.neuro.2008.07.005_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0301-0082(96)00027-5","article-title":"The effects of methylenedioxymethamphetamine (MDMA \u201cEcstasy\u201d) on monoaminergic neurotransmission in the central nervous system","volume":"49","author":"White","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuro.2008.07.005_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008877-200008000-00001","article-title":"A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon","volume":"11","author":"Wolff","year":"2000","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib53","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/187152706777950693","article-title":"Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade","volume":"5","author":"Wood","year":"2006","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.neuro.2008.07.005_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1254\/jjp.48.145","article-title":"The involvement of serotonergic and dopaminergic systems in hypothermia induced in mice by intracerebroventricular injection of serotonin","volume":"48","author":"Yamada","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.neuro.2008.07.005_bib55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3565(25)22061-4","article-title":"Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine","volume":"227","author":"Yamawaki","year":"1983","journal-title":"J Pharmacol Exp Ther"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X08001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X08001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:05:15Z","timestamp":1738317915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X08001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0161813X08001393"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2008.07.005","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}